株式会社極東書店トップ ＞ 商品一覧 ＞ Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice?. 1st ed. 2022
商品詳細
Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice?. 1st ed. 2022
【Open Accessタイトル】
・ISBN 978-3-030-89124-4 paper EUR 29.99
￥8,015.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
お気に入り
★★★
| 著者・編者 | Velasquez, German, |
|---|---|
| シリーズ | (SpringerBriefs in Public Health) |
| 出版社 | (Springer Nature Switzerland AG, SZ) |
| 出版年月 | 2021 |
| ページ数 | 117 pp. |
| 言語 | ENG |
| ニュース番号 | ＜A02-17789＞ |
解説
This open access book is a collection of research papers on COVID-19 by German Velasquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership?
The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members.
In this single volume, the chapters present the progress of thinking and debate - particularly in relation to drugs and vaccines - that wouldenable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered:
The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members.
In this single volume, the chapters present the progress of thinking and debate - particularly in relation to drugs and vaccines - that wouldenable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered:
- COVID-19 Vaccines: Between Ethics, Health and Economics
- Medicines and Intellectual Property: 10 Years of the WHO Global Strategy
- Re-thinking Global and Local Manufacturing of Medical Products After COVID-19
- Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock
- Intellectual Property and Access to Medicines and Vaccines
- The World Health Organization Reforms in the Time of COVID-19